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AUTOMATED BREATHING AND METABOLIC SIMULATOR (ABMS) 
EVALUATION OF N95 RESPIRATOR USE WITH SURGICAL MASKS 
 
Edward James Sinkule, Ph.D. 
 
 
Objective:  To reduce the threat of exhausting N95 filtering face piece respirator (FFR) 
supplies during pandemic influenza outbreaks, the Institute of Medicine has recommended 
using surgical mask covers (SM) over  FFR among healthcare workers as one strategy to 
avoid surface contamination of the FFR.  The objective of this investigation was to measure 
and evaluate breathing air quality (average inhaled CO2 and O2 concentrations), peak 
inhalation (InPr) and exhalation (ExPr) breathing pressures, and average inhaled dry-bulb 
(Tdb) and wet-bulb (Twb) temperatures when using FFR with FDA-cleared SM and without 
SM.     
Methods:  Thirty NIOSH-approved FFR models with and without SM were 
evaluated using the NIOSH Automated Breathing and Metabolic Simulator (ABMS).  The 
ABMS protocol consisted of the following levels of O2 consumption, CO2 production, and 
minute ventilation performed consecutively for minimum of five min each (units in STPD):  
0.5, 0.4, and 9.8 L∙min-1; 1.0, 0.8, and 25.3 L∙min-1; 1.5, 1.3, and 38 L∙min-1; 2.0, 1.9, and 62 
L∙min-1; 2.5, 2.5, and 70 L∙min-1; and 3.0, 3.15, and 80 L∙min-1, respectively.    
Results:  The mean across all FFR without SM (FFR-alone) for average inhaled CO2 
and O2 ranged from 2.7% and 17.1%, respectively, for the lowest metabolic rate to 1.7% and 
19.2%, respectively, for the greatest metabolic rate.  The mean across all FFR with SM 
(FFR+SM) for average inhaled CO2 and O2 ranged from 3.0% and 16.7%, respectively, for 
  
 
v 
the lowest metabolic rate to 1.9% and 18.9%, respectively, for the greatest metabolic rate.  
The mean across all FFR-alone for InPr and ExPr ranged from -5 and 7 mmH2O, 
respectively, for the lowest metabolic rate to -41 and 24 mmH2O, respectively, for the 
greatest metabolic rate.  The mean across all FFR+SM for InPr and ExPr ranged from -7 and 
8 mmH2O, respectively, for the lowest metabolic rate to -51 and 30 mmH2O, respectively, for 
the greatest metabolic rate.  The mean across all FFR-alone for Tdb and Twb ranged from 29 
to 27°C, respectively, for the lowest metabolic rate to 32 and 28°C for the greatest metabolic 
rate.  The mean across all FFR+SM for Tdb and Twb ranged from 29 to 27°C, respectively, 
for the lowest metabolic rate to 33 and 30°C for the greatest metabolic rate.   
When grouped by respirator type and compared to FFR-alone, average inhaled CO2 
concentration was significantly higher for cup FFR+SM and significantly lower for 
horizontal flat-fold FFR+SM.  Reciprocal significant changes were observed for average 
inhaled O2 concentrations.  ExPr was significantly higher for cup FFR+SM at V
.
O2 >1.0 
L∙min-1.  InPr was significantly higher for cup FFR+SM at all levels of energy expenditure, 
and higher for other flat-fold FFR+SM at V
.
O2 >1.5 L∙min-1.  Tdb and Twb was significantly 
higher for cup FFR+SM at V
.
O2 >0.5 L∙min-1.   
Conclusions:  The orientation of the SM on the FFR may have a significant effect on 
the inhaled breathing quality at lower levels of energy expenditure and breathing pressures at 
higher levels of energy expenditure.  The measureable InPr and ExPr caused by SM on FFR 
for healthcare users likely will be imperceptible at lower activity levels.  While statistically 
significant, the changes in Tdb and Twb for FFR+SM compared to FFR-alone were small. 
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1.0  INTRODUCTION 
 
 
 
1.1  Rationale 
 
At the request of the Department of Health and Human Services, the Institute of Medicine 
(IOM) convened a Committee on the Development of Reusable Facemasks for Use During 
an Influenza Pandemic in order to report on the solutions, limitations, threats, and possible 
opportunities of reusing respirators for infection control during an influenza pandemic 
(National Academy of Sciences, 2006).  The Committee offered recommendations for 
extending the life of disposable N95 filtering face piece respirators (FFR) for individual 
users.  One recommendation involved limiting contamination by placing a surgical mask 
over the respirator in order to prevent surface contamination and extending the usefulness of 
the FFR during a shift.  Previous research reported elevated concentrations of inhaled carbon 
dioxide (CO2) and decreased concentrations of inhaled oxygen (O2) associated with wearing 
FFRs (Sinkule, Turner, and Hota, 2003).  Others have proposed that the adverse effects of 
wearing FFR (e.g., headache and increased sick days) are the result of elevated inhaled CO2 
concentrations (Lim et al. 2006).  The increased inhaled CO2 concentrations and decreased 
inhaled O2 concentrations within the breathing zone of negative-pressure (air-purifying) 
respirators, including FFR, are directly related to dead space(Sinkule, Turner, and Hota, 
2003; Sinkule and Turner, 2004).  No study examined the effects of the increased resistance 
from the application of a surgical mask (SM) on the characteristics of FFR and FFR dead 
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space.  It is unknown, therefore, how the Committee’s recommendation will affect the 
breathing gas concentrations and breathing resistance of FFR users. 
The computer-controlled Automated Breathing and Metabolic Simulator (ABMS) is 
an ideal laboratory device for evaluating inhaled CO2 and O2 concentrations and resistance 
pressures in respirators due to its high degree of accuracy and repeatability in duplicating 
human CO2 production and O2 consumption.  The ABMS produces CO2 and simulates O2 
consumption at fixed breathing frequencies and tidal volumes to simulate human metabolic 
processes.  The goal of this study was to characterize the inhaled CO2 concentrations, inhaled 
O2 concentrations, and inhalation and exhalation pressures of NIOSH-certified FFR with and 
without a FDA-cleared SM using an ABMS-based test. 
The selection of NIOSH-certified FFR was determined by several criteria including 
the market share of three types of FFR, each with and without exhalation valves.  The three 
types were cup, horizontal flat-fold, and other flat-fold.  Market share was acquired through 
interview with trade organizations and respirator distributors.  Preference was assigned to 
those FFR and surgical mask cover (SM) contained within the U.S. Strategic National 
Stockpile (SNS).  The SM used was Medline NON27382 which was also in the SNS.  This 
SM was a random selection between two SM available from the SNS that did not have ear 
loops for attachments thus compatible with a head form without ears.   
The information from this investigation will be used to generate a report from NIOSH 
that could be used to influence recommendations on extending the lifetime of FFRs using a 
SM as a protective covering.  The ABMS test method developed to investigate the use of 
N95 with SMs will be shared with the group from the International Organisation of Standards 
responsible for ABMS test standards (ISO / TC94 / Standards Committee 15 / Working 
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Group 1 / Project Group 4 – Respiratory Protective Device Test Methods) and the American 
National Standards Institute (ANSI).  The information collected from this project may be 
used in the development of a NIOSH test method. Depending on the results, the information 
may be used to launch another investigation using human volunteers.  For a human research 
study, this simulator study will provide the direction and magnitude of expected changes, 
identify any unexpected changes that may subject human volunteers to unhealthy or 
hazardous conditions, and provide the information needed to configure the sample size. 
 
1.2  Purpose 
The major purpose of this study was to evaluate the inhaled CO2 and O2 concentrations and 
breathing resistance of NIOSH-certified FFRs with and without a FDA-cleared SM using an 
ABMS-based test.  An ABMS test protocol, which is valid and relevant for the FFR class, 
was used to characterize performance in terms of average inhaled CO2 concentrations, 
average inhaled O2 concentrations, and inhalation and exhalation pressures.  The evaluations 
were repeated with the same FFRs worn while using a FDA-cleared SM as a protective 
covering.  The investigation for measuring inhaled CO2 and O2 concentrations for FFRs with 
SMs will benefit: 1) policymakers when they make recommendations for extending the life 
of disposable FFRs, 2) those involved in testing and certifying these respirators by providing 
them with a valid, consistent method for evaluating inhaled CO2 and O2 concentrations, 3) 
workers required to wear these types of respirators by ensuring that inhaled breathing gas 
concentrations and resistances will be within acceptable limits, and 4) industrial hygienists 
that make respirator selections by providing an objective, repeatable test method for inhaled 
CO2 concentrations for these types of respirators.    
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1.3  Research Hypotheses 
1. A SM on FFRs will cause higher inhaled CO2 concentrations compared to FFRs 
alone. 
2. A SM on FFRs will cause lower inhaled O2 concentrations compared to FFRs alone. 
3. A SM on FFRs will cause higher peak inhalation and exhalation pressures compared 
to FFRs alone. 
4. A SM on FFRs without exhalation valves will cause higher peak inhalation and 
exhalation pressures compared to a SM on FFRs with exhalation valves. 
 
1.4  Significance 
At the request of the Department of Health and Human Services, the Institute of Medicine 
convened a Committee on the Development of Reusable Facemasks for Use During an 
Influenza Pandemic in order to report on their solutions, limitations, threats, and possible 
opportunities of reusing respirators as a control for healthcare and public health applications 
during a pandemic (National Academy of Sciences, 2006).  The Committee offered 
recommendations for extending the life of disposable FFRs for individual users.  One 
recommendation involved limiting contamination by placing a SM over the respirator in 
order to prevent surface contamination.  It is unknown if the Committee considered whether 
the addition of the SM would increase the physiological burden of wearing a FFR.  Changes 
caused by the addition of a SM could include increased levels of CO2, breathing resistance, 
and temperature, and decreased levels of O2.  There is no NIOSH certification test that 
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measures minimum and average inhaled carbon dioxide (CO2) concentrations, or maximum 
and average inhaled oxygen (O2) concentrations for FFRs.   
The effects of wearing FFR and other types of respiratory protection have been 
widely studied using a variety of measurement methods (Li et al., 2005).  Some of these 
investigations have been quantitative (e.g., levels of inhaled CO2), qualitative (e.g., levels of 
fatigue), or can reflect characteristics that range from inconvenient (e.g., decreased levels of 
comfort) to hazardous (e.g., decreased inhaled levels of O2).  FFR use has been associated 
with an increased frequency of headaches and sick days (Lim et al. 2006).  The physiological 
effects of breathing ~3 - 4% inhaled CO2 include impaired visual performance (Yang et al. 
1997), decreased exercise endurance (Raven et al. 1979), and severe dyspnea, headache, 
dizziness, and perspiration occurs if inhaled CO2 is ~7% (Compressed Gas Association, 
1999).  Psychological effects include decreased reasoning and alertness, and increased 
irritability when inhaled CO2   concentration was 6.5%; and short-term memory loss at 7.5% 
(Sayers et al. 1987).  Subjects performing physical activity while breathing decreased O2 
concentrations (17%) experienced higher levels of lactic acid accumulation at lower levels of 
energy expenditure compared to normal O2 concentrations, in addition to achieving lower 
levels of peak exercise performance (Hogan et al. 1983).  Increased breathing resistance from 
respirators has been identified as the cause of respiratory fatigue and impaired physical work 
capacity, a shift to anaerobic metabolism from an increased rate of oxygen debt; early 
exhaustion at lighter workloads; and headache and dyspnea with inhaled CO2 concentrations 
of 3%  (Raven et al. 1979).  Increased subjective fatigue and mental errors have been 
associated with wearing SMs (Raven et al. 1979).  In a study that compared physiologic 
effects and subjective perceptions of comfort between using FFRs and SMs, significantly 
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higher levels of heart rate, mask temperature and humidity occurred during FFR wear 
compared to the SMs (Li et al. 2005).  While wearing SMs, subjects felt drier, cooler, 
breathed easier and were more comfortable compared to wearing FFRs.  Since some studies 
did not measure inhaled concentrations of CO2 or O2, or end-tidal PCO2, the relationship of 
objective and subjective responses to gas concentrations could not be made.  To date, no 
laboratory or field studies have been published to provide data on the effect from protective 
(e.g., SMs) on the concentrations of respiratory gases in the breathing zone of FFRs.  
Subjective effects are associated with user comfort.  Comfort, or discomfort, may be 
extensive enough to cause the wearer to remove the respiratory protection or prevent the 
wearer from donning respirators.  One example is inhalation temperature.  Normally, 
exhalation temperature is several degrees (Celsius) lower than body temperature.  The next 
inhaled breath will include the dead air space mixed with the temperature of ambient air.  
The upper respiratory tract will warm and humidify the inhaled air to physiologic levels prior 
to entry in the lower respiratory area. This arrangement is different for wearers of negative 
pressure non-powered air purifying respirators, such as FFRs.  The inhaled air within the 
breathing zone of the respirator is warmed from the preceding breath.  A greater relative 
portion of the breath is pre-warmed from the respirator for smaller individuals compared to 
larger ones with a relative smaller tidal volume.  With increased physical activity or ambient 
temperature conditions, increased body temperature will cause higher exhaled air 
temperatures.  The burden of additional breathing resistance from respirators will increase 
the basal metabolic requirements from additional aerobic work by the respiratory accessory 
muscles.   While wearing negative pressure respiratory protection, the inhaled temperature 
(and humidity) may affect the wearer’s subjective level of comfort and capacity to wear the 
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respirator for extended periods of time.  For this investigation, no human subjects will be 
used to report subjective comfort measurements.  Inhalation temperature (dry-bulb) and wet-
bulb temperature will be measured and reported.  The inhaled and exhaled dry-bulb and wet-
bulb temperatures will be used to determine the humidity of the inhaled and exhaled air while 
wearing the respirators with and without SMs.  
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2.0  LITERATURE REVIEW 
 
2.1  Introduction 
Primary respiratory responses to breathing through a negative pressure respiratory protective 
device include increased inhaled concentrations of CO2 which would cause hypercapnia and 
decreased inhaled concentrations of O2 which would cause hypoxia.  Secondary responses 
include reduced inspiratory and expiratory ventilation times and smaller tidal volumes from 
increased inhalation and exhalation resistance (pressure). 
The following chapter provides an overview of the respiratory consequences from 
breathing while wearing respiratory protection. 
 
2.2  Respiratory Response Mechanisms with Respiratory Protection 
Within the last 10 years, there has been increased awareness of elevated concentrations of 
inhaled CO2 and decreased levels of inhaled oxygen (O2) concentration associated with 
wearing respiratory protection.  Field data suggest that CO2 concentrations in several 
nonNIOSH-certified surgical helmets ranged from 0.55 to 1.17% during a 15-minute 
sampling period (Echt et al. 1996).  A recent study found CO2 levels exceeding the NIOSH 
STEL1 of 3% in a prototype powered air-purifying respirator (PAPR) operating with the 
blower turned off (Beeckman, Turner, and Campbell, 1998).  Average inhaled CO2 
concentrations were shown to exceed 2.0% in a wildland fire fighter’s particulate filtering 
                                                 
1 Short-term exposure limits (STEL's) are based on a 15-minute time-weighted average exposure that should not be 
exceeded at any time during a workday. Exposures at the STEL should not be longer than 15 min and should not be repeated 
more than four times per day. 
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device during testing over a range of work rates.  NIOSH reported extremely high inhaled 
CO2 concentrations and low inhaled O2 concentrations in three nonNIOSH-certified air-
purifying escape hood respirators evaluated with the automated breathing and metabolic 
simulator (average inhaled  CO2 concentrations range:  0.5 – 6.5% at the lowest level of 
energy expenditure; average inhaled O2 concentrations range:  13.4 – 8.8%); in men during 
treadmill exercise (minimum inhaled CO2 concentrations range:  0.4 – 2.3% at the lowest 
level of energy expenditure; maximum inhaled O2 concentrations range:  19.9 – 19.0%); and 
in women during treadmill exercise (minimum inhaled CO2 concentrations range:  0.9 – 
4.0% at the lowest level of energy expenditure; maximum inhaled O2 concentrations range:  
19.6 – 17.0%) (Sinkule and Turner, 2004).  The NIOSH IDLH2 value for CO2 is 40,000 ppm, 
or 4%.  As a result of this research, NIOSH developed a standard test procedure (STP 0454) 
to measure inhaled CO2 and O2 concentrations for air-purifying escape-only respirators 
during physical activity (NIOSH, 2006). 
Recently, NIOSH reported increased levels of CO2 concentrations using an automated 
breathing and metabolic simulator at the lowest levels of energy expenditure among negative 
pressure respirators; with FFRs having the highest average inhaled CO2 and O2 
concentrations of 3.5% and 16.8%, respectively (Sinkule, Turner, and Hota, 2003).  Twenty-
six different models from 17 manufacturers representing each type of FFR (cup, cup with fit 
enhancements, cone/duck-bill, and flat-folding) were examined.  Results indicated the 
highest inhaled CO2 values among the cup type with fit enhancements (a foam shell molded 
into the facial contact area used to improve the respirator’s fit characteristics), especially at 
                                                 
2 Immediately dangerous to life or health; a concentration from which a worker could escape without injury or without 
irreversible health effects in the event of respiratory protection equipment failure (e.g., contaminant breakthrough in a 
cartridge respirator or stoppage of air flow in a supplied-air respirator) and a concentration above which only "highly 
reliable" respirators would be required. 
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the lower levels of energy expenditure.  The other respirators included approximately 390 
models of various powered air-purifying respirators, elastomeric air-purifying respirators, 
air-supplied respirators with an airline (positive pressure devices), and gas masks.  
2.3  The Automated Breathing and Metabolic Simulator 
 
The computer-controlled Automated Breathing and Metabolic Simulator (ABMS) produces 
CO2 and simulates O2 consumption at fixed breathing frequencies and tidal volumes to 
simulate human metabolic processes (Deno, 1984 and Kyriazi, 1986).  The ABMS is an ideal 
device for evaluating inhaled CO2 and O2 concentrations in respirators due to its high degree 
of accuracy and repeatability in duplicating human CO2 production and O2 consumption. 
Several metabolic simulators have been developed, including machines used for 
evaluating military aircraft, evaluating crew conditions aboard vessels for space flight, and 
“calibrators” for metabolic measurement systems.  Breathing machines have been used for 
testing and certifying respirators in the United States since 1970 (Kyriazi, 1986).  These 
machines have several advantages, which are as follows:  breathing machines relieve the 
need of using human test subjects;  respirators which have been developed with a novel 
design or respirators which have been used can be characterized without causing a threat to 
human test subjects; and the mechanical and electrical engineering used in the operation of 
the breathing machines provide very accurate reproducibility between test periods and 
between the respirators that are to be evaluated.  The disadvantages to breathing machines 
include the unpredictable frequency to mechanical and electronic malfunctions and wear, and 
current breathing machines cannot physiologically respond to changes caused by a respirator.  
Two types of breathing machines have been used for the evaluation of respirators, 
breathing simulators (or, breathing machines) and a combination of breathing and metabolic 
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simulators.  Breathing simulators are designed to simulate the characteristics of the human 
breathing pattern during respiratory ventilation, i.e.  inhalation and exhalation.  Typically, 
these machines include a motor-driven rotating cam that is connected to piston.  The piston 
moves inside a fixed volume cylinder.  The motor speed is determined by the respiration rate 
needed to maintain minute ventilation.  Breathing and metabolic simulators are designed to 
simulate the characteristics of both human breathing and metabolic functions.  By design, a 
metabolic simulator replicates breathing ventilation (respiratory frequency, tidal volume, 
flow, temperature and humidity), O2 consumption, and CO2 production.  Where the breathing 
simulator uses air at ambient conditions, a metabolic simulator produces human respiratory 
air qualities at approximately 33ºC and saturated with water vapor.3  Due to their complexity, 
metabolic simulators usually are managed by a computer program.  The computer uses a 
routine of energy expenditures (protocol) to make adjustments and provide measurements of 
respiratory gas concentrations, pressures and temperatures.  A protocol can be a single level 
of exercise, described by a constant V
.
E, V
.
O2, V
.
CO2 and breathing waveform, for any desired 
duration.  A protocol also can be a series of different levels of energy expenditures with 
correspondingly different V
.
E, V
.
O2, V
.
CO2 and breathing waveforms, which may contain 
periods of similar or different durations. The computer programming performs adjustments to 
the lung motor and to the metabolic valves for breath-by-breath exhaust, CO2 and nitrogen 
concentrations in order to maintain the criteria set forth in the protocol.  During these 
adjustments, the computer displays the metabolic measurements (all output volumetric values 
in STPD unless stated otherwise) on a video display terminal and printer, and logs the 
information in a temporary data file. 
                                                 
3 While 37ºC represents the resting human temperature, this parameter can be modified to a similar exercising 
human temperature of 38-39ºC.  
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There has been one benchmark research report where the responses from the ABMS 
with air-purifying escape hoods for use in a chemical, biological, or radioactive, or nuclear 
contaminated environment (CBRN) were similar as responses from human subject volunteers 
using the same respiratory protection (Sinkule and Turner, 2004).  A statistical comparison 
between the ABMS and human subject data was not conducted. 
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3.0  METHODS 
 
 
 
3.1  Respirator and SM Selection 
 
This study was a laboratory-based evaluation using the ABMS to assess inhaled CO2 and O2 
concentrations and breathing resistance (inhalation and exhalation pressures) caused by 
NIOSH-certified non-powered air-purifying respirators (disposable N95 particulate filtering 
face piece respirators, or FFR) with and without FDA-cleared SMs.  The N-series respirator 
is restricted for use in workplaces free of oil aerosols, and 95 means the filter device is 95% 
efficient for filtering a mean particle size up to 0.075 ±0.020 micrometer (Figure 1).  Bacteria 
may be as small as 0.2 micrometer contained within a fluid medium.  FFR are a preferred 
respiratory protection device for healthcare because it is disposable, inexpensive, and meets 
filtration standards by NIOSH. In addition to filtration, NIOSH performs the following 
evaluations for FFR certification:  breathing resistance (≤35mmH2O for inhalation and 
≤25mmH2O for exhalation at 85 ±2 liters∙min-1 constant flow) and exhalation valve leak (≤30 
ml∙min-1 at 25mmH2O inhalation pressure).  A sample of four respirators of a consistent 
common size (medium, medium/large, or universal) of each the following types initially were 
included in the research design:  
 
 N95 cup 
 N95 cup with fit enhancement (foam face, or fit, shell) 
 N95 duck-bill 
 N95 flat-fold 
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Figure 1.  Example of NIOSH-approved N95 particulate filtering facepiece respirators. 
a, N95 cup.  b, N95 cup with fit shell.  c, N95 cone/duck bill.  d, N95 horizontal flat-fold 
 
In the sample of FFR used in this investigation, including those from the SNS, 
“medium” sized FFR were selected when various sizes were available.  Size specifications of 
several FFR, however, included intermediate sizes, such as “one-size-fits-all” (also known 
as, “universal size”) and “medium-large” size.  Intermediate sizes and manufacturer-specific 
FFR were unbalanced in the sample between FFR with and without exhalation valves (Table 
1).  In addition, the sizes between models of FFR for the same manufacturer may not be 
equal.  Furthermore, since there are no federal, industry, or standards body regulations for 
sizing FFR, dissimilar sizes between manufacturers occurred and would affect respirator 
dead-space.   
a b 
d c 
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At the beginning of the study, market changes were discovered and additional FFR in 
the U.S. Strategic National Stockpile required several changes in the selection of NIOSH-
approved FFR.  Market analyses were acquired through trade organizations and respirator 
distributors.  First, an insufficient number of N95 cup FFR with fit shell were available in the 
N95 configuration.  The “cup” type of FFR for analysis included cup FFR with and without 
fit shells, and with and without exhalation valves.  Second, NPPTL management requested 
investigating additional FFR selected from the U.S. Strategic National Stockpile (SNS) (U.S. 
Department of Health and Human Services,  2009).  The SNS is a large quantity of medicines 
and medical supplies maintained by the Centers for Disease Control and Prevention and the 
U.S. Department of Health and Human Services, mandated by Congress in 1999.  The 
supplies within the SNS are to be used during national disasters or outbreaks when the local 
necessary supplies critically would be strained or exhausted.  Preference was assigned to 
those respirators contained within the SNS.  Third, in order to maintain a balanced design of 
FFR types after FFR from the SNS were selected, two additional FFR configurations were 
included – vertical flat-fold and tri-fold FFRs  (Figure 2), and  with and without exhalation 
valves.  The vertical flat-fold FFR and the tri-fold FFR were combined into the “other flat-
fold” type of FFR.  Two duck-bill FFR were included in the sub-set of horizontal flat-fold 
FFR because they appeared similar with a horizontal fold that separated the top half and 
bottom half.   The duck-bill FFR and horizontal flat-fold FFR, both with and without 
exhalation valves, were combined into the sub-set of “horizontal flat-fold” FFR.  The type of 
FFR respirator is determined by the market and is not recognized classification in a NIOSH 
standard.  The final groupings used in the research design were as follows:  cup, horizontal 
flat-fold, and other flat-fold (Table 1).  
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Figure 2.  Added FFR to the research design. 
 a, vertical flat-fold FFR; and b, tri-fold FFR 
 
 
According to the NIOSH Certified Equipment List, there are approximately 350+ 
models of NIOSH-approved FFR manufactured for use in the United States (NIOSH, 2011).  
The NIOSH Certified Equipment List (CEL) is a web-based repository of current and past 
NIOSH-certified respirators.  The number of available nonNIOSH-approved N95 FFR 
models is unknown.  After this investigation was launched, the NIOSH-approved FFR was 
expanded with more FFR available in the SNS.  None of the FFR from the SNS contained 
exhalation valves.  The final FFRs selected, therefore, included additional FFR types from 
the SNS and a balance of FFR types with exhalation valves.  The number of FDA-cleared 
SM models and NIOSH-approved FFR models was limited due to the urgency of available 
data needed for policy guidance and a restriction of project funding.  
SMs are evaluated under the guidance of the FDA, a.k.a. FDA-cleared, for fluid 
resistance, filtration efficiency, breathing resistance, and flammability.  The tests may be 
conducted by an independent laboratory or a manufacturer’s laboratory, and then reported to 
a b 
    17  
 
the FDA by the SM manufacturer.  The FDA does not conduct laboratory evaluations for 
clearing SMs.  A SM may be of several types, e.g. pleated, flat-fold, cup, etc.  A SM also 
may be a NIOSH-certified FFR.  A combination NIOSH-certified FFR and FDA-cleared SM 
need only supply the NIOSH certification number (for filter efficiency and breathing 
resistance) with results for fluid resistance and flammability.  The selection of the FDA-
cleared SM was based on the models available within the SNS (Figure 3).  The SM was a 
random selection between two SM available from the SNS that did not have ear loops for 
attachments thus compatible with a head form without ears.       
   
Figure 3.  Examples of surgical mask covers. 
a, FDA-cleared surgical mask from U.S. Strategic National Stockpile (Medline NON27382).   
b, non-FDA-cleared surgical mask. 
 
3.2  Automated Breathing and Metabolic Simulator (Figures 4 and 5) 
 
The automated breathing and metabolic simulator (ABMS) with the abilities to simulate O2 
consumption, CO2 production, and ventilation with heated and humidified air is ideal for 
quantitative and repeatable testing and evaluation of FFR (Figures 4 and 5).  The ABMS 
(Ocenco, Inc., Pleasant Prairie, WI) has the capability to simulate the following metabolic 
parameters:  O2 consumption rate, CO2 production rate, respiratory frequency, tidal volume, 
a b 
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breathing waveform shape, and heated and humidified breathing gas.  In addition, any 
number of work rates may be combined in any order to simulate various activities.  The 
capacity ranges for the parameters are as follows:  minute ventilation, 0-160 L∙min-1; O2 
consumption, 0-7 L∙min-1; CO2 production, 0-7 L∙min-1; respiratory frequency, 0-100 
breaths∙min-1;  tidal volume, 0-5 liters; and human-like breathing gas temperatures, 30-45 ºC.  
All gas volume parameters are at STPD (standard temperature (0 ºC) and pressure (760 
mmHg), dry, unless stated otherwise.  A sinusoid waveform was used for ventilation rates 
below 50 L∙min-1.  A trapezoid or human-like waveform was used for ventilation rates above 
50 L∙min-1. 
The ABMS monitored the following parameters:  flow-weighted average inhaled 
concentrations of O2 and CO2 concentrations, peak inhalation and exhalation breathing 
pressures, and inhaled dry-bulb and wet-bulb gas temperatures.  The capacity ranges for 
these parameters are as follows:  O2 concentration, 0-100%; CO2 concentration, 0-15%; 
breathing pressure, ±700 millimeters of water (H2O); and inhaled dry-bulb and wet-bulb 
temperatures, 0-100ºC.  The cyclic changes seen at the mouth of the ABMS reflect inhaled 
air concentrations from the environment and respirator dead space, adjusted by subtracting 
the gas transport time and analyzer response time, and weighing the instantaneous CO2 and 
O2 concentrations by the air flow rate in order to account for the relative contribution of the 
gases at each point under the flow curve.  The average inhaled gas concentrations were 
determined by electronically measuring the instantaneous gas concentrations at the mouth 
(see placement of the “O2 and CO2 sample line”, Figure 5) at a high sampling rate (200 Hz), 
weighing each value by multiplying it by the instantaneous flow rate, multiplying each 
product by the sampling interval, summing the volumes over inhalation, and dividing the  
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Figure 4.  Automated breathing and metabolic simulator (ABMS). 
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Figure 5.  Exposed trachea from ABMS.  Head form removed to expose the following  
sample lines:  dry-bulb thermocouple, wet-bulb thermocouple, pressure transducer, exhaust 
gases, combined O2 and CO2 gas sample line. 
 
volume of inhaled CO2 and O2 by the breath volume.  A more detailed explanation is given in 
the appendix of the public document by Kyriazi (1986).  Deno (1984) provides a description 
of the development of the ABMS. 
3.3  Research Design and Variables 
 
This study used a cross-sectional experimental design with 2x2x3 (surgical mask x 
exhalation valve x FFR type) factorial analysis of variance.  The dependent variables were 
Wet-bulb thermocouple 
Line to pressure transducer 
O2 and CO2 sample line 
Dry-bulb thermocouple 
To exhaust pump 
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average inhaled CO2 concentration, average inhaled O2 concentration, peak inhalation 
pressure, and peak exhalation pressure.  Statistics were performed on average inhaled dry-
bulb temperature and average inhaled wet-bulb temperature but the differences were very 
small.  In this case, temperature within the FFR was difficult to interpret since heat from a 
user’s face was not available and did not contribute to the temperature within each FFR.  For 
each dependent variable, comparisons between the treatment (SM versus no SM) were 
performed for FFR with and without exhalation valves and for each type of FFR (cup, 
horizontal flat-fold, and other flat-fold).   
Models of each type of FFR in the U.S. Strategic National Stockpile were selected to 
represent the SNS (Authorization of Emergency Use of Certain Personal Respiratory 
Protection Devices; Availability, 2009); in addition, similar models with exhalation valves 
and other popular models from the market were evaluated.  All tests were repeated with a 
FDA-cleared SM also selected from the SNS.  The total number of respirators tested were 
approximately 15 models x 2 exhalation valve configurations (with and without) x 4 
respirator trials x 2 FDA-cleared surgical-mask configurations (with and without) = 240 tests.   
Thirty NIOSH-approved disposable FFR models were selected for this investigation.  
Among the 30 respirator models, 18 were of the cup type, six of the horizontal flat fold type, 
and six of the other flat fold type.  The “other flat-fold” types included three vertical flat fold 
and three tri-fold respirators.  Table 1 provides the grouping among the respirator models for 
each type and the presence of an exhalation valve.   One FDA-cleared flat-fold SM was 
included as a treatment for comparison among each respirator model and is present in the 
SNS.  The SM used was Medline NON27382 which was also in the SNS (see Figure 3a).   
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Table 1:  Grouping of the FFR Type and Valve  
 
 FFR type              FFR without Exhalation Valve                FFR with Exhalation Valve                       
 
  Cup                     3M 1860 (M)†                                          3M 8211 (O) 
                              3M 8000 (O)†                                          3M 8212 (O) 
                              3M 8210 (O)†                                          3M 8511 (O) 
                              Inovel 3002 (M)†                                     3M 8512 (O) 
                              AO Safety N9504C (O)*                         AO Safety N9505C (O)*  
                              Crews RPN951 (O)*                                Crews RPN952 (O)* 
                              Gerson 1730 (O)*†                                  Gerson 1740 (O)* 
                              Moldex 2200 (M/L)*†                             Moldex 2300 (M/L)* 
                              Moldex-Metrics 2600 (M/L)*                  Moldex-Metrics 2700 (M/L)* 
  
  Horizontal           Kimberly-Clark 46727 (O)†                    Willson N9520FM (M) 
  Flat-fold              Crews RPFN951 (O)*                              Crews RPFN952 (O)* 
                              San Huei SH2950 (O)*                            San Huei SH2950V (O)* 
 
  Other                   3M 1870 (O)†                                          Dräger Piccola (O) 
  Flat-fold              3M 9210 (O)*†                                        3M 9211 (O)* 
                              San Huei SH3500 (O)*                            San Huei SH3500V (O)* 
________________________________________________________________________                                                                                                                                               
Respirators are FFR (size) 
M = medium size, M/L = medium/large size, O = one-size-fits-all/universal size 
* Paired-valve respirators:  the same FFR with or without an exhalation valve 
† Selected FFR from the Strategic National Stockpile 
 
Each week, FFR testing was preceded by instrument calibration (pressure transducer, 
and both dry-bulb and wet-bulb thermocouples) and room-air validation studies.  The room-
air validation studies were performed on the exhaust gases as a means of confirming 
calibrated metabolic valves, sampling times, and lung volumes.  Lung volume was 
electronically controlled by a stepper motor.  The ABMS O2 and CO2 analyzers were 
calibrated using standard calibration gases (15% O2 and 8% CO2) before each trial.  In 
addition, the response time (<100 milliseconds) and transport time (<300 milliseconds) were 
calculated electronically before each trial in these fast-response gas analyzers then used to 
electronically offset sample time.  According to the manufacturers’ instructions, respirators 
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were placed on the head form attached to the trachea of the ABMS.  A sealant (Poli-Grip®) 
was applied to the contact area between the head form and respirator in order to create a seal 
between the facial surface of the head form with each FFR.  The face seal with a NIOSH-
approved FFR among human users is assessed with a fit-test.  No sealant was used while 
donning a SM to the FFR since a fit-test is not needed for using surgical masks.  FFRs, with 
and without SM, were tested for a minimum of 5 minutes at each work rate.  For the ABMS, 
minute ventilation, O2 consumption and CO2 production change instantaneously between 
changes in energy expenditures which produce a rapid change (< 1 minute) in measured gas 
concentrations and steady state.     
The breathing frequencies (f), tidal volumes (VT), minute ventilation rates (V˙ E), O2 
consumption rates (  V˙O2 ), CO2 production rates (V˙ CO2), and respiratory quotients (R) 
programmed into the ABMS are shown in Table 2.  These metabolic rates represent a 
progression from light to very intense energy expenditures.  For health care workers, the 
range of energy expenditure can be from very light (e.g., desk work used for writing patient 
notes, 1.8 METs; or performing procedures in an operating room, 3 METs) to moderate (e.g., 
moving patients 34 kilograms or more, 7.5 METs) to very hard (e.g., responding to 
emergency calls by paramedics, patient care by physical therapists, and emergency calls 
performed by flight nurses, >10 METs) (Ainsworth et al., 2000).  One MET (metabolic 
equivalent) is equal to a resting metabolic rate, or 3.5 ml of O2 consumed∙kg-1∙min-1. 
The metabolic rates are comparable to a draft international standard (ISO/TS 16876-
1) for a person with a body surface area of 1.8 m2 (1.75 meters in height and 70 kilograms in 
weight): V
.
O2 (STPD): 0.5 L∙min-1, 0.9 L∙min-1, 1.5 L∙min-1, 2.1 L∙min-1, 2.5 L∙min-1, and 3.1 
L∙min-1; and V
.
E (BTPS): 16 L∙min-1, 27 L∙min-1, 48 L∙min-1, 66 L∙min-1, 78 L∙min-1, and 99  
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L∙min-1. In the past (Morris, 1991) as well as in the current standard, V
.
CO2 was assigned the 
same value as V
.
O2 because it assumed that the respiratory quotient (R) was equal to 1 or the 
value was not cited.  Throughout the spectrum of normal physical activity, the respiratory 
quotient will range from 0.80 to >1.0, which is the same as Table 2.  
In a randomized fashion, models of FFR and the same models of FFR with the 
selected SM were evaluated as the test conditions.  Flow-weighted average inhaled CO2 and 
O2 concentrations, peak inhaled and exhaled pressures at the mouth, average inhaled wet-
bulb, and dry-bulb temperatures were measured by the ABMS, and arithmetic means of these 
variables were calculated.  The data during the last minute of each variable at each level of 
energy expenditure (Table 2) for each condition (FFR only and FFR with SM) were used for 
analysis.   
 
 
Table 2:   Metabolic Variables for the ABMS Exercise Protocol 
 
Test 
Level 
f 
(breath/min) 
VT 
(Liters, 
STPD) 
V
.
E 
(L∙min-1, 
STPD) 
V
.
O2 
(L∙min-1, 
STPD) 
V
.
CO2 
(L∙min-1, 
STPD) 
 
R 
1 12.9 0.76 9.8 0.5 0.4 0.80 
2 19.5 1.30 25.3 1.0 0.8 0.80 
3 28.0 1.36 38.0 1.5 1.3 0.87 
4 32.6 1.90 62.0 2.0 1.9 0.95 
5 34.2 2.05 70.0 2.5 2.5 1.00 
6 36.4 2.20 80.0 3.0 3.15 1.05 
      (f = frequency of breathing; VT = tidal volume; V
.
E = minute ventilation, expired; 
       V
.
O2 = oxygen consumption; V
.
CO2 = carbon dioxide production; R = respiratory 
       Quotient)  
 
 
 
When all the experimental trials were concluded, an examination of the variances 
among the trails revealed inconsistencies which required more trials for approximately six 
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FFR models to improve homogeneity of the results. Two-hundred eighty-one trials were 
completed, or an average of 4.7 trials for each FFR model tested with and without a SM.   
Results included the mean and standard deviation of the following dependent 
variables for each respirator model tested under conditions with and without a SM:  average 
inhaled CO2 concentration, average inhaled O2 concentration, peak inhaled and exhaled 
pressures at the mouth, average inhaled wet-bulb temperature, and average inhaled dry-bulb 
temperature.  In this investigation, average inhaled temperature (determined by the dry-bulb 
and wet-bulb temperature measurements) was considered a variable of comfort and does not 
present a respiratory or metabolic risk compared to the inhaled gases and peak breathing 
pressures.  Limited statistical analyses were performed on temperature because its relevance 
was limited.  No temperature information from the face could be included because the head 
form was near room temperature and did not sweat.  A facial surface temperature less than 
normal body temperature may have been responsible for FFR temperatures lower than 
expected.  If additional information should become available that suggests that humidity or 
temperature triggers a larger concern than originally thought, then additional statistical 
analyses were included.   
The research questions were as follows:   
Using the ABMS throughout the range of energy expenditures, what were the effects 
on inhaled CO2 and O2 concentrations, and peak inhalation and exhalation pressures 
caused by: 
1. Selected NIOSH-certified FFRs? 
2. Selected NIOSH-certified FFRs with exhalation valves? 
3. Selected NIOSH-certified FFRs covered with a FDA-cleared SM? 
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4. Selected NIOSH-certified FFRs with exhalation valves and covered with a FDA-
cleared SM? 
3.4  Sample Size and Statistical Analyses 
  
Data from a previous NIOSH study that investigated the inhaled CO2 concentrations in 
various respirators using the ABMS (Sinkule et al. 2003) were used to determine sample 
sizes in the current study.  The primary measure of interest, for purposes of estimating the 
study’s power, was the minimal fractional inhaled CO2 concentration (expressed here as a 
percent).  The mean fractional minimal inhaled CO2 concentration was 0.25%, the within-
group, or within-respirator standard deviation (pooled over the different units) was 0.09%.  
The between-group variability represented 94.4% of the overall variability in CO2 
measurements.  For the initial power estimate, the analysis of variance contrast between 
those with and without a SM will have similar power to the 2-sample t-test with a pooled 
standard deviation of 0.09% and a sample size of n = 0.944×96, which (conservatively) ≈ 90 
per group (Neter et al., 1985).  The following results give power estimates for different 
assumptions about the primary difference in minimal inhaled CO2 concentrations between 
those tests with and without a SM; all estimates are based on a 1-sided test (which assumes 
that the CO2 measurement can only be greater, or the same, with the SM). 
 
CO2 level    Statistical 
(with a SM):    Power: 
0.26%    18.4% 
0.27%    43.9% 
0.28%    72.3% 
0.29%    90.9% 
0.30%    98.1% 
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For example, compared to the fractional minimal inhaled CO2 concentration within the N95 
without a SM, we have a 98.1% probability of a true hypothesis if the difference detected in 
the minimal inhaled CO2 concentration of a FFR with a SM is at least 0.05% (the difference 
in the minimal inhaled CO2 concentration of a FFR without a SM, 0.25%, and the minimal 
inhaled CO2 concentration of a FFR with a SM, 0.30%).  The sample size, therefore, of four 
respirators of each model were tested for 5 minutes at each O2 consumption rate.  Respirators 
were tested randomly according to type. 
Dependent variables (average inhaled CO2 concentrations, average inhaled O2 
concentrations, and peak inhalation and exhalation pressures) were analyzed using 2x2x3 
(SM x exhalation valve x FFR type) factorial analysis of variance (ANOVA).  For each 
dependent variable, comparisons between the treatment (SM versus no SM) were performed 
for respirators with and without exhalation valves and for each type of respirator (cup, 
horizontal flat-fold, and other flat-fold).  If necessary, the Tukey multiple comparison test 
was used for all post hoc analysis of significant effects.  Statistical significance for ANOVA 
and Tukey analyses was set at P<0.05.  Data analyses were performed using SPSS, version 
18 (SPSS, Inc., Chicago, IL).
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4.0  RESULTS 
 
4.1  Respiratory Gases 
 
Results for the average inhaled CO2 concentration (expressed as percent) among FFR with 
and without SM are shown in Table 3.  Among the six levels of energy expenditure, the 
average inhaled CO2 concentrations were higher (p<0.05) among the cup FFR with SM 
compared to cup FFR alone at 0.5 L∙min-1, 2.5 L∙min-1, and 3.0 L∙min-1.  The average inhaled 
CO2 concentrations were lower (p<0.05) among horizontal flat-fold FFR with SM compared 
to horizontal flat-fold FFR alone at 1.0 L∙min-1 and 1.5 L∙min-1.  The average inhaled CO2 
concentrations were not different between other flat-fold FFR with and without SM.  A 
significant (p<0.05) main effect was observed for average inhaled CO2 by the following 
variables:  FFR type at 2OV of  0.5 L∙min
-1, 1.0 L∙min-1, and 1.5 L∙min-1; and, exhalation 
valve at 2OV of  0.5 L∙min
-1, 1.0 L∙min-1, 1.5 L∙min-1, 2.0 L∙min-1, 2.5 L∙min-1, and 3.0 
L∙min-1.  Significant interactions (p<0.05) between N95 type and exhalation valve on average 
inhaled CO2 concentration were observed for 2OV of 0.5 L∙min
-1 only; between FFR type and 
SM use for 2OV of 1.0 L∙min
-1, 2.5 L∙min-1, and 3.0 L∙min-1; between FFR with exhalation 
valves and SM use at 2OV of 1.5 L∙min
-1, 2.0 L∙min-1, 2.5 L∙min-1, and 3.0 L∙min-1.   
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Table 3:  Average Inhaled Carbon Dioxide Concentrations  (%) Among FFR With and 
Without SM   
                                                                  
Oxygen Consumption,                                                           Horizontal                  Other 
         L∙min-1                 Treatment           Cup (n = 18)     Flat-fold (n = 6)      Flat-fold (n = 6)   
 
           0.5                       N95 only              2.49 ± 0.51          3.52 ± 0.93            2.65 ± 0.57 
                                       N95 + SM            2.93 ± 0.38∗        3.14 ± 0.64            3.13 ± 0.40 
 
           1.0                       N95 only              1.64 ± 0.53          2.87 ± 1.12            1.93 ± 0.66 
                                       N95 + SM            1.98 ± 0.39          2.00 ± 0.44∗          2.01 ± 0.12 
 
           1.5                       N95 only              2.09 ± 0.82          3.23 ± 1.32            2.31 ± 0.94 
                                       N95 + SM            2.31 ± 0.41          2.30 ± 0.46∗          2.21 ± 0.09 
 
           2.0                       N95 only              1.43 ± 0.60          1.81 ± 0.82            1.65 ± 0.73 
                                       N95 + SM            1.75 ± 0.33          1.67 ± 0.33            1.58 ± 0.15 
 
           2.5                       N95 only              1.28 ± 0.57          1.66 ± 0.77            1.52 ± 0.73 
                                       N95 + SM            1.65 ± 0.38∗        1.52 ± 0.26            1.48 ± 0.16 
 
           3.0                       N95 only              1.52 ± 0.65          1.90 ± 0.87            1.79 ± 0.89 
                                       N95 + SM            1.99 ± 0.33∗        1.75 ± 0.32            1.71 ± 0.22 
                                                                                                                                                    _          
Values are means ± SD 
N95 only = FFR alone, N95 + SM = FFR with SM cover 
∗Significantly different from N95 only, p<0.05 
 
 
Results for the average inhaled O2 concentration (expressed as percent) among FFR 
with and without SM are in Table 4.  Among the six levels of energy expenditure, the 
average inhaled O2 concentrations were lower (p<0.05) among the cup FFR with SM  
compared to cup FFR alone at 0.5 L∙min-1, 2.5 L∙min-1, and 3.0 L∙min-1.  The average inhaled 
O2 concentrations were higher (p<0.05) among horizontal flat-fold FFR with SM compared 
to horizontal flat-fold FFR alone at 1.0 L∙min-1 and 1.5 L∙min-1.  The average inhaled O2 
concentrations were not different between other flat-fold FFR with and without SM.  A 
significant (p<0.05) main effect was observed for average inhaled O2 by the following 
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variables:  FFR type at 2OV of  0.5 L∙min
-1, 1.0 L∙min-1, and 1.5 L∙min-1; and, exhalation 
valve at 2OV of  0.5 L∙min
-1, 1.0 L∙min-1, 1.5 L∙min-1, 2.0 L∙min-1, 2.5 L∙min-1, and 3.0 
L∙min-1.   Significant (p<0.05) interactions between FFR type and exhalation valve on 
average inhaled O2 concentration were observed for 2OV of 0.5 L∙min
-1 only; between FFR 
type and SM use for 2OV of 1.0 L∙min
-1, 1.5 L∙min-1, and 3.0 L∙min-1; between FFR with 
exhalation valves and SM use at 2OV of 1.5 L∙min
-1, 2.0 L∙min-1, 2.5 L∙min-1, and 3.0 
L∙min-1.   
 
Table 4:  Average Inhaled Oxygen Concentrations (%) Among FFR With and Without SM   
                                                                  
Oxygen Consumption,                                                           Horizontal                  Other 
         L∙min-1                 Treatment           Cup (n = 18)     Flat-fold (n = 6)      Flat-fold (n = 6)   
 
           0.5                       N95 only            17.40 ± 0.81         16.10 ± 1.14          17.31 ± 0.77 
                                       N95 + SM          16.81 ± 0.54∗       16.52 ± 0.79          16.58 ± 0.67 
 
           1.0                       N95 only            18.84 ± 0.77         17.30 ± 1.39          18.47 ± 0.89 
                                       N95 + SM          18.39 ± 0.50         18.39 ± 0.55∗        18.29 ± 0.17 
 
           1.5                       N95 only            18.49 ± 1.04         17.15 ± 1.52          18.22 ± 1.13 
                                       N95 + SM          18.22 ± 0.49         18.25 ± 0.51∗        18.25 ± 0.09 
 
           2.0                       N95 only            19.33 ± 0.70         18.92 ± 0.84          19.08 ± 0.84 
                                       N95 + SM          18.96 ± 0.37         19.05 ± 0.35          19.05 ± 0.15 
 
           2.5                       N95 only            19.52 ± 0.65         19.12 ± 0.77          19.26 ± 0.82 
                                       N95 + SM          19.11 ± 0.41∗       19.25 ± 0.28          19.19 ± 0.16 
 
           3.0                       N95 only            19.32 ± 0.71         18.95 ± 0.83          19.03 ± 0.96 
                                       N95 + SM          18.82 ± 0.38∗       19.06 ± 0.34          18.98 ± 0.23 
                                                                                                                                                    _          
Values are means ± SD 
N95 only = FFR alone, N95 + SM = FFR with SM cover 
∗Significantly different from N95 only, p<0.05 
 
    31  
 
4.2  Breathing Pressures 
 
Peak inhalation and exhalation pressures are used as measures of breathing resistance.  
Results for peak exhalation pressure (expressed in mmHg) among FFR with and without SM 
are in Table 5.  Among the six levels of energy expenditure, the peak exhalation pressures 
were higher (p<0.05) among the cup FFR with SM compared to cup FFR alone at 1.5 
L∙min-1, 2.0 L∙min-1, 2.5 L∙min-1, and 3.0 L∙min-1.  Peak exhalation pressures were not 
different between horizontal flat-fold FFR with or without SM, nor between other flat-fold 
FFR with or without SM.  In addition, a significant (p<0.05) main effect of SM use and FFR 
with an exhalation valve on peak exhalation pressure was observed for 2OV of  1.5 L∙min
-1, 
2.0 L∙min-1, 2.5 L∙min-1, and 3.0 L∙min-1. 
Results for peak inhalation pressure among FFR with and without SM are in Table 6.  
Among the six levels of energy expenditure, the peak inhalation pressures were higher 
(p<0.05) among the cup FFR with SM compared to cup FFR alone at every level of O2 
consumption.  Peak inhalation pressures were different between other flat-fold FFR with or 
without SM at the 2OV  of 2.0 L∙min
-1, 2.5 L∙min-1, and 3.0 L∙min-1.  Peak inhalation 
pressures were not different between horizontal flat-fold FFR with and without SM.    In 
addition, a significant (p<0.05) main effect of SM use on peak inhalation pressure was 
observed for 2OV of 1.0 L∙min
-1, 1.5 L∙min-1, 2.0 L∙min-1, 2.5 L∙min-1, and 3.0 L∙min-1. 
The presence of an exhalation valve may affect breathing pressure response.  Fifteen 
of the 30 FFR contained an exhalation valve.  The exhalation valve is a flexible dam (usually 
made of rubber) anchored to a circular frame that is mounted in the wall of the FFR directly 
in the front of the breathing zone.  The circular frame has adequate venting to facilitate the 
flow of air during exhalation.  The valve is anchored with a flexible connection so that it can 
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passively lift from its frame with positive mask pressure created by exhalation and allow the 
valve to become seated against the valve frame between breaths.  The valve prevents inward 
leakage of ambient air during exhalation and during the isovolumic period between 
inhalation and exhalation.  Upon negative mask pressure created by inhalation, the flexible 
dam is pulled into its frame to create a seal and prevent air leak into the FFR mask.  Table 7 
contains results of peak inhalation and exhalation pressures in FFR with and without 
exhalation valves compared to FFR with and without SM. 
 
Table 5:  Peak Exhalation Pressures (mmH2O) Among FFR With and Without SM   
                                                                  
Oxygen Consumption,                                                           Horizontal                  Other 
         L∙min-1                 Treatment           Cup (n = 18)     Flat-fold (n = 6)      Flat-fold (n = 6)   
 
           0.5                       N95 only                   8 ± 2                   7 ± 2                      7 ± 4 
                                       N95 + SM                 8 ± 2                   8 ± 2                      9 ± 3 
 
           1.0                       N95 only                  10 ± 3                 11 ± 3                     9 ± 3 
                                       N95 + SM                12 ± 3                 12 ± 3                   11 ± 2 
 
           1.5                       N95 only                  14 ± 4                 15 ± 3                    14 ± 4 
                                       N95 + SM                17 ± 4∗               18 ± 4                    17 ± 2 
 
           2.0                       N95 only                  23 ± 7                 24 ± 4                    22 ± 6 
                                       N95 + SM                29 ± 7∗               30 ± 8                    28 ± 4 
 
           2.5                       N95 only                  20 ± 6                 21 ± 4                    19 ± 5 
                                       N95 + SM                25 ± 6∗               26 ± 6                    24 ± 4 
 
           3.0                       N95 only                  24 ± 8                 25 ± 4                    23 ± 6 
                                       N95 + SM                30 ± 7∗               31 ± 8                    29 ± 4 
                                                                                                                                                    _          
Values are means ± SD 
N95 only = FFR alone, N95 + SM = FFR with SM cover 
∗Significantly different from N95 only, p<0.05 
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Table 6:  Peak Inhalation Pressures (mmH2O) Among FFR With and Without SM   
                                                                  
Oxygen Consumption,                                                           Horizontal                  Other 
         L∙min-1                 Treatment           Cup (n = 18)     Flat-fold (n = 6)      Flat-fold (n = 6)   
 
           0.5                       N95 only                  -6 ± 1                  -5 ±    2                    -6 ±   2 
                                       N95 + SM                -7 ± 2∗                -6 ±    2                    -7 ±   1 
 
           1.0                       N95 only                 -12 ± 2                -12 ±    4                 -12 ±   2 
                                       N95 + SM               -15 ± 3∗              -14 ±    5                 -14 ±   2 
 
           1.5                       N95 only                  -19 ± 4               -19 ±    6                 -18 ±   2 
                                       N95 + SM                -23 ± 5∗             -23 ±    8                 -23 ±   3 
 
           2.0                       N95 only                  -35 ± 6                -34 ± 10                 -33 ±   3 
                                       N95 + SM                -41 ± 7∗              -43 ± 16                 -44 ± 11∗ 
 
           2.5                       N95 only                  -35 ± 6                -34 ± 10                 -33 ±   3 
                                       N95 + SM                -42 ± 8∗              -44 ± 16                 -45 ± 12∗ 
 
           3.0                       N95 only                  -41 ± 7                -42 ± 13                 -40 ±   3 
                                       N95 + SM                -49 ± 9∗              -54 ± 22                 -56 ± 17∗ 
                                                                                                                                                    _          
Values are means ± SD 
N95 only = FFR alone, N95 + SM = FFR with SM cover 
∗Significantly different from N95 only, p<0.05 
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Table 7:  Peak Inhalation and Exhalation Pressures (mmH2O) Among FFR With and Without 
Exhalation Valves Between FFR With and Without SM    
     Oxygen                                         Peak Inhalation Pressure      Peak Exhalation Pressure                 
Consumption, 
   L∙min-1                 Treatment          Plain N95       N95 + EV      Plain N95         N95 + EV   
 
        0.5                   N95 only               -6 ±   1           -5 ±   2            7 ±   2              8 ±  2 
                                N95 + SM             -7 ±   2           -7 ±   2∗          8 ±   2              8 ±  3 
 
        1.0                   N95 only             -11 ±   2         -12 ±   3          11 ±   3            10 ±  3 
                                N95 + SM           -14 ±   3∗       -15 ±   4∗        13 ±   2∗          10 ±  3 
 
        1.5                   N95 only             -18 ±   3         -20 ±   4          16 ±   4            13 ±  4 
                                N95 + SM           -22 ±   4∗       -24 ±   6∗        19 ±   3∗          15 ±  3 
 
        2.0                   N95 only              -33 ±   5        -36 ±   8          27 ±   6            20 ±  5 
                                N95 + SM            -40 ±   8∗      -45 ± 11∗        33 ±   6∗          25 ±  5∗ 
 
        2.5                   N95 only              -33 ±   5        -36 ±   8          23 ±  5             17 ±  5 
                                N95 + SM            -40 ±   8∗      -45 ± 12∗        28 ±  5∗           22 ±  4∗ 
 
        3.0                   N95 only              -39 ±   5        -43 ±   9          27 ±  6             20 ±  6 
                                N95 + SM            -49 ± 12∗      -54 ± 15∗        34 ±  6∗           26 ±  5∗ 
                                                                                                                                                    _          
Values are means ± SD 
N95 only = FFR alone, N95 + SM = FFR with SM cover 
N95 alone = FFR without exhalation valve, N95 + EV = FFR with exhalation valve 
∗Significantly different from N95 only, p<0.05 
 
4.3  Inhaled Breathing Temperatures 
 
Results for average inhaled dry-bulb temperature (degrees Celsius) among the types of FFR 
are in Table 8.  The dry-bulb temperature for the cup FFR with SM were different from cup 
N95 without SM at V
.
O2 of 1.0 L∙min-1, 1.5 L∙min-1, 2.0 L∙min-1, 2.5 L∙min-1, and 3.0 L∙min-1.  
Average inhaled dry-bulb temperatures were not different between horizontal flat-fold FFR 
with and without SM, nor between other flat-fold FFR with and without SM.  In addition, a 
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significant (p<0.05) main effect of FFR with an exhalation valve and SM use on average 
inhaled dry-bulb temperature was observed for 2OV of 1.5 L∙min
-1, 2.0 L∙min-1, 2.5 L∙min-1, 
and 3.0 L∙min-1.  Significant (p<0.05) interactions between FFR with exhalation valves and 
SM use on average inhaled dry-bulb temperature at 2OV of 1.5 L∙min
-1, 2.0 L∙min-1, 2.5 
L∙min-1, and 3.0 L∙min-1. 
 Results for average inhaled wet-bulb temperature (degrees Celsius) among the 
types of FFR are in Table 9.  The average inhaled wet-bulb temperature for the cup FFR with 
SM were different from cup N95 without SM at 1.0 L∙min-1, 1.5 L∙min-1, 2.0 L∙min-1, 2.5 
L∙min-1, and 3.0 L∙min-1.  Average inhaled wet-bulb temperatures were not different between 
horizontal flat-fold FFR with and without SM, nor between other flat-fold FFR with and 
without SM.  In addition, a significant (p<0.05) main effect of FFR with an exhalation valve 
on average inhaled wet-bulb temperature was observed for 2OV of 1.0 L∙min
-1, 1.5 L∙min-1, 
2.0 L∙min-1, 2.5 L∙min-1, and 3.0 L∙min-1; and, SM use on average inhaled wet-bulb 
temperature for 2OV of 1.5 L∙min
-1, 2.0 L∙min-1, 2.5 L∙min-1, 3.0 L∙min-1.  Significant 
(p<0.05) interactions between FFR with exhalation valves and SM use on average inhaled 
wet-bulb temperature at 2OV of 1.5 L∙min
-1, 2.0 L∙min-1, 2.5 L∙min-1, and 3.0 L∙min-1. 
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Table 8:  Average Inhaled Dry-Bulb Temperatures (degrees Celsius) Among FFR With and 
Without SM   
                                                                  
Oxygen Consumption,                                                           Horizontal                  Other 
         L∙min-1                  Treatment           Cup (n = 18)     Flat-fold (n = 6)      Flat-fold (n = 6)   
 
           0.5                       N95 only                 29 ± 1                 29 ± 1                    28 ± 1 
                                       N95 + SM               29 ± 1                 30 ± 1                    29 ± 1 
 
           1.0                       N95 only                  31 ± 1                 32 ± 2                   31 ± 1 
                                       N95 + SM                32 ± 1∗               32 ± 1                   31 ± 1 
 
           1.5                       N95 only                  32 ± 1                 33 ± 2                    32 ± 1 
                                       N95 + SM                33 ± 1∗               33 ± 1                    32 ± 1 
 
           2.0                       N95 only                  32 ± 1                 33 ± 1                    32 ± 1 
                                       N95 + SM                33 ± 1∗               34 ± 1                    33 ± 1 
 
           2.5                       N95 only                  32 ± 1                 32 ± 1                    32 ± 1 
                                       N95 + SM                33 ± 1∗               33 ± 1                    33 ± 1 
 
           3.0                       N95 only                  32 ± 1                 33 ± 1                    32 ± 1 
                                       N95 + SM                33 ± 1∗               34 ± 1                    33 ± 1 
                                                                                                                                                    _          
Values are means ± SD 
N95 only = FFR alone, N95 + SM = FFR with SM cover 
∗Significantly different from N95 only, p<0.05 
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Table 9:  Average Inhaled Wet-Bulb Temperatures (degrees Celsius) Among FFR With and 
Without SM   
                                                                  
Oxygen Consumption,                                                           Horizontal                  Other 
         L∙min-1                  Treatment           Cup (n = 18)     Flat-fold (n = 6)      Flat-fold (n = 6)   
 
           0.5                       N95 only                 27 ± 1                 27 ± 2                    26 ± 1 
                                       N95 + SM               28 ± 1                 27 ± 1                    27 ± 1 
 
           1.0                       N95 only                  28 ± 1                 29 ± 2                   28 ± 1 
                                       N95 + SM                29 ± 1∗               30 ± 1                   28 ± 1 
 
           1.5                       N95 only                  29 ± 2                 30 ± 3                    29 ± 1 
                                       N95 + SM                30 ± 1∗               31 ± 1                    30 ± 1 
 
           2.0                       N95 only                  29 ± 2                 30 ± 3                    29 ± 1 
                                       N95 + SM                30 ± 2∗               31 ± 1                    29 ± 1 
 
           2.5                       N95 only                  27 ± 2                 28 ± 3                    28 ± 1 
                                       N95 + SM                29 ± 2∗               30 ± 1                    28 ± 1 
 
           3.0                       N95 only                  28 ± 2                 29 ± 3                    28 ± 1 
                                       N95 + SM                30 ± 2∗               30 ± 1                    29 ± 1 
                                                                                                                                                    _          
Values are means ± SD 
N95 only = FFR alone, N95 + SM = FFR with SM cover 
∗Significantly different from N95 only, p<0.05 
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5.0  DISCUSSION 
 
5.1  N95 Respirators (FFR) and Surgical Mask Covers (SM) 
 
The purpose of this investigation was to characterize the inhaled breathing gas concentrations 
and breathing pressures among a representative sample of FFR with and without a SM using 
the ABMS.  Breathing temperatures were examined as an indication of user comfort.  The 
main sample of FFR was changed due to changes in the SNS and the market from the 
beginning of the investigation, which removed a type of FFR (FFR cup with fit seal) and 
increased the sample by the FFR added to the SNS.  These modifications changed FFR type 
groupings while maintaining selections with current market conditions. 
The Certified Equipment List, maintained by NIOSH, provides the public with 
information of the NIOSH-approved FFR including NIOSH-approved FFR with expired 
certifications.  The sample used in this investigation represented approximately 10% of the 
approximately 350 NIOSH-approved FFR.  Not all of the NIOSH-approved FFR are sold in 
the United States.  According to a manufacturer, the following four FFR used in this 
investigation were not sold through distributors in the United States but could be procured 
through internet sources:  San Huei SH2950, San Huei SH2950V, San Huei SH3500, and 
San Huei SH3500V. 
The basis for FFR participation in the SNS was determined by the NIOSH approval.  
Nine FFRs were FFR models also within the SNS.  None of the FFR selected from the SNS 
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had exhalation valves.  If healthcare professionals were to use FFR with exhalation valves 
and the SM in the event of reduced FFR supplies, the added SM protection could prevent 
exhaled contamination by the wearer, based on size of the infectious aerosol alone 
(Rengasamy et.al., 2009).   
5.2  Respiratory Gases 
 
Previous research has provided a basis for changes that occur in respiratory gases from 
respirator use, that is, respirator dead space. Increased dead space causes an increase in tidal 
volume and respiratory rate (Harber et al., 1982).  Sinkule, et.al. (2003) investigated five 
types of respiratory protection using the ABMS:  air-purifying respirators (n = 27), air-
supplied respirators (n = 20), gas masks (n = 6), powered air-purifying respirators (n = 11), 
and FFR (n = 26).  Using the same six levels of energy expenditure as the present 
investigation, FFR produced the highest levels of average inhaled CO2 concentrations and 
lowest average inhaled O2 concentrations for all levels of energy expenditure compared to all 
other respiratory protective devices examined.  Table 3 contains average inhaled CO2 
concentrations among the FFR used in the present investigation.  The practical significance 
of these findings includes the influence of dead-space upon the CO2 concentrations among 
horizontal flat-fold FFR, which were larger in comparison than the other types of FFR 
without a SM.  The average inhaled CO2 concentrations were above the NIOSH STEL of 
0.5% among all levels of energy expenditure, without and with SM.   Individually, three of 
the 30 FFR tested without SM produced average inhaled CO2 concentrations above 4%, 
which is Immediately Dangerous to Life and Health (IDLH).  IDLH is the designation of 
maximal exposure above which only highly reliable respiratory protection provides maximal 
worker protection.  One FFR (AOSafety Pleats Plus) was withdrawn from the analysis based 
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upon the exceptionally large average inhaled CO2 concentration – 5.8% at 2OV of 0.5 
L∙min-1.  This high level of CO2 exposure is above the NIOSH Ceiling of 3% and IDLH of 
4%.  The NIOSH Ceiling is used to describe occupational exposures that shall not be 
exceeded through any part of the workday (American Conference of Governmental Industrial 
Hygienists, 2011).  The performance of this FFR model was a true outlier that skewed 
analyses.  Manufacturing of this FFR was discontinued through the course of this 
investigation.   
The respirator provides a micro-environment for the exposure pathway of CO2 
(Nieuwenhuijsen, 2006; Checkoway, Pearce, and Kriebel, 2004).  The user’s exposure to 
CO2 concentrations include those from multiple sources; e.g., from the respirator and from 
others within the room.  According to CFR 42 Part 84, the highest inhaled CO2 concentration 
permitted for respiratory protection is 2.5% lasting ≤30 minutes for the self-contained 
breathing apparatus (Approval of Respiratory Protection Devices, 2006b).  A standard test 
procedure (STP) used by NIOSH for the evaluation of negative-pressure air-purifying 
hooded respirators for escape only contains an inhaled CO2 concentration threshold of 2.5% 
for apparatus of 15-30 minutes duration, and 2.0% for an apparatus of 45-60 minutes 
duration (National Institute for Occupational Safety and Health, 2006).  This STP is the only 
evaluation of inhaled CO2 and O2 in human participants among negative-pressure air-
purifying respirators, including FFR.  Of the FFR in this investigation, average inhaled CO2 
was likely to be lower than 2.0% for levels of energy expenditure at 2.0 L∙min-1 or greater, 
both without and with a SM.  At levels of energy expenditure of 1.5 L∙min-1 or lower, 
average inhaled CO2 appeared likely to be above 2.0% for all FFR and more so at the lowest 
level of energy expenditure (rest).  
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Respiratory rate, tidal volume, and alveolar CO2 become elevated with inhaled CO2 
concentrations above ambient (Consolazio, Fisher et al., 1947; Schneider and Truesdale, 
1922; Patterson et al., 1955).  These physiological responses occur to compensate for 
abnormal diffusion of CO2 from the blood, due to a decrease in the ratio of alveolar to 
capillary CO2 (Schulte, 1964).  In addition to the increased rate and depth of breathing, 
cardiac output will increase to compensate for the additional CO2 (Schulte, 1964).  While 
inhaling 1 – 2% CO2 for 17 to 32 minutes, slight increases have been reported in systolic and 
diastolic blood pressures (Schneider and Truesdale, 1922).  Exposures of increased inhaled 
CO2 between 2 – 3% have been known to produce sweating, headache and dyspnea for some 
subjects at rest after several hours (Schneider and Truesdale, 1922).  If inhaled CO2 
concentrations occur between 4 – 5%, dyspnea can occur within several minutes and 
increased blood pressure, dizziness and headache can occur within 15-32 minutes (Patterson 
et al., 1955; Schneider and Truesdale, 1922; Schulte, 1964).  As noted in several of these 
studies, headaches have been reported at inhaled CO2 concentrations similar to those found in 
this investigation.  This is consistent with one study which found that 37% of healthcare 
workers surveyed reported headaches following FFR use (Lim et al., 2006).          
A striking unanticipated finding among the horizontal flat-fold FFR was a reduction 
in the average inhaled CO2 concentration when a SM was applied as an additional layer of 
protection at 2OV of 1.0 and 1.5 L∙min
-1.  The high average inhaled CO2 concentrations 
among horizontal flat-fold FFR without a SM were caused by the larger respirator dead-
space compared to the cup type of FFR or other flat-fold FFR.  The additional respirator 
dead-space was increased by inflating the horizontal flat-fold FFR during exhalation.  During 
inhalation with the horizontal flat-fold, the FFR collapsed against the head form face.  The 
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application of the horizontal flat-fold type of SM -- a glove-to-hand sleeve over the 
horizontal flat-fold FFR -- restricted the inflation effect during exhalation and reduced the 
dead-space.  The average inhaled CO2 concentration among cup FFR increased among those 
with a SM compared to those without the SM at 2OV of  0.5, 2.5 and 3.0 L∙min
-1, due to the 
additional dead space caused by the horizontal flat-fold type of SM.  For the other flat-fold 
FFR, three FFR were of the tri-fold type and three FFR were of the vertical flat-fold type.  
The orientation of these other flat-fold types on the user’s face and other dead space features 
would affect the average inhaled CO2 concentrations.  With a SM cover, the orientation of 
the other flat-fold FFR (vertical flat-fold and tri-fold) would change on the user’s face.  
Placing a horizontal flat-fold SM on a vertical flat-fold FFR would require bending the 
corners/ends of the vertical flat-folds, which likely would decrease the dead space within the 
FFR.  Bending of the folds in tri-folded FFR would be needed with the application of a 
horizontally flat-folded SM cover, which also would reduce the dead space in the FFR.  Any 
bending or folding of the FFR filter material also compromises the total surface area of the 
filter media and filtration efficiency.  The variability of the average inhaled CO2 
concentration results among the various types of flat-fold FFR combined in the “other flat 
fold” category contributed to insignificant differences between this type of FFR with and 
without SM.       
The effect of the additional inhaled concentrations of CO2 would result in 
physiological changes which would not be seen in an ABMS that does not respond to 
increased concentrations of CO2.  The effects on humans, therefore, depend on the amount of 
respirator dead space and the tidal volume of the user.  The data used to program the ABMS 
for the minute ventilation, respiratory rate, O2 consumption, and CO2 concentration at each 
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level of energy expenditure originated from healthy men with body weight between 85-92 
kilograms.  If the FFR user is smaller by body weight with a concomitant reduction in tidal 
volume, the effects from the FFR dead space would be greater; higher average inhaled CO2 
concentrations and lower average inhaled O2 concentrations would be observed (Sinkule and 
Turner, 2004).  In a responding human, the elevated CO2 concentrations would cause 
hyperventilation (increased tidal volume and respiratory rate); sweating; headache; dizziness; 
and, increases in cardiac output, diastolic and systolic blood pressures. 
The changes in average inhaled O2 concentration closely followed the expected 
reciprocal changes in average inhaled CO2 concentration, whereas average inhaled O2 
concentration increased in conditions where average inhaled CO2 concentration decreased 
and vise versa.  One reason for the changes in average inhaled O2 concentration relative to 
average inhaled CO2 concentration is because of the relative displacement of the gases in air; 
the changes in one gas directly allows for a greater or lesser proportion of the other gases.  
Like the unanticipated change that occurred among the horizontal flat-fold FFR, where a 
reduction in the average inhaled CO2 concentration was observed when a SM was applied as 
an additional layer of protection at 2OV of 1.0 and 1.5 L∙min
-1, an increase in the average 
inhaled O2 concentration also occurred for this select sub-set of FFR.  According to CFR 42 
Part 84 (Approval of Respiratory Protection Devices, 2006a), a hazardous atmosphere occurs 
in any O2-deficient atmosphere of less than a partial pressure of 148 mmHg, or 19.5%.  From 
Table 4, the average inhaled O2 concentration was below 19.5% for all conditions for all 
levels of energy expenditure, except for the condition of “N95 only” at the level of O2 
consumption of 2.5 L∙min-1.   The average inhaled O2 concentration of ≤15% occurred in one 
FFR without SM during the 0.5 and 1.5 L∙min-1 levels of energy expenditure.  In a clinical 
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trial, inhaled oxygen concentration of 15%  caused more time needed to travel a standard 
distance with the lowest power output measured and coincided with the highest measured 
capillary blood lactate concentrations when compared to normoxia and hyperoxia (FIO2, 
100%); caused muscle fatigue, reduced calcium ion released from the sarcoplasmic 
reticulum, increased minute ventilation by 26%, and decrease O2 consumption by 10% 
(Amann et al., 2006).  At the threshold partial pressure of O2 at 132 mmHg (17.4% O2), 
symptoms include headache, lightheadedness, drowsiness, muscular weakness, dyspnea on 
exertion, nausea, and vomiting (Schulte, 1964).  Neurological symptoms, such as reduced 
memory and mental work capacity, auditory and visual disturbances, vertigo, tinnitus, and 
irritability, may be manifested if O2 deficiency continues (Schulte, 1964). 
5.3  Breathing Pressures 
 
The peak inhalation and exhalation pressures could impact respirator comfort, in addition to 
inhalation and exhalation temperatures, respirator weight, respirator valves, etc.  The 
increased pressure may cause a decrease in respiratory rate (Harber et al., 1982; Louhevaara, 
1984) and tidal volume (Harber et al., 1982).  Among older individuals, respiratory rate may 
not change and tidal volume decreases with increased inspiratory resistance (Louhevaara, 
1984). Table 5 (Peak Exhalation Pressures) and Table 6 (Peak Inhalation Pressures) show 
how the breathing pressures increase with energy expenditure where respiratory rate and tidal 
volume cause more air flow during inhalation and exhalation.  During exhalation, the 
differences between FFR with and without SM occur only in cup type of FFR.  The 
difference in the group with the largest representation (cup type with 60% of the sample) 
would explain the variation.  No differences between the FFR at the lowest levels of energy 
expenditure occurred with the lowest tidal volumes and peak flows vis-à-vis half the sample 
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contained FFR with exhalation valves.  In a previous NIOSH investigation of FFR breathing 
pressures with and without SM using a breathing machine, mean FFR alone and without 
exhalation valves (three models) at minute ventilations of 1.0 and 1.5 L∙min-1 with a 
sinusoidal breathing waveform reported exhalation pressures of 7 and 11 mmH2O, 
respectively (Vojtko et al., 2008).  From the same report, the mean FFR with a SM at minute 
ventilations of 1.0  and 1.5 L∙min-1 and sinusoidal breathing waveform reported mean 
exhalation pressures of  8 and 12 mmH2O, respectively.  In FFR with exhalation valve (one 
model), Vojtko reported 4 and 5 mmH2O, respectively, at 1.0 and 1.5 L∙min-1 for FFR alone; 
and, 4 and 6 mmH2O, respectively, for FFR with SM.  The most significant factors 
contributing to the differences between the data reported from this study and the Vojtko 
study could be due a larger sample size (30 FFR models versus 4 FFR models) and the 
difference in the minute ventilation expressed by the Vojtko study (atmospheric temperature 
and pressure (ATP), ambient) and the present study (STPD).  The conversion from ATP to 
STPD (used from the ABMS) would change minute ventilation from 25 to 22 L∙min-1 and 
from 40 to 35 L∙min-1 (Cotes, Chinn, and Miller, 2006).  Thus, the corrected minute 
ventilations from the manikin data used in the Vojtko et al. (2008) study are lower when 
adjusted to the same volumetric format used in the present study. 
Clinically, it would be important to know when humans find the added pressure from 
FFR wear intolerable or the point where users detect the added pressure from a SM.  Two 
reports investigated the minimal pressures that can be detected in humans from elastic and 
non-elastic loads (Bennett et al., 1962; Campbell et al., 1961).  Bennett et al. (1962) 
conducted a study using added restrictive loads to measure the ability to determine the lowest 
restriction noticeable by humans.  Participants were asked to breathe (assuming inhalation 
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and exhalation were weighted equally) through progressively narrowed tubes (between 2 – 
12 mmH2O∙liter-1∙second-1) which were previously calibrated with a water manometer.  The 
mean 50% level of detection was 6 mmH2O∙liter-1∙second-1 (BTPS).  Bennett reported a non-
linear relationship between the pressure and flow characteristics for each load.  The 
relationship between the results from Bennett et al. (1962) and the ranges of pressures in 
Table 8, the mean exhalation pressures (Table 5), and the mean inhalation pressures (Table 
6), can be used to estimate the level of energy expenditure where a SM addition to using a 
FFR is detected by humans.  During exhalation (Table 5), the difference in pressures at the 
energy expenditure commensurate with the flow rate in the Bennett study (at V
.
O2 between 
0.5 and 1.0 L∙min-1 by the ABMS) between FFR and FFR+SM were smaller than the 50% 
level of detection for each flow.  The same comparison analysis among the FFR and 
FFR+SM during inhalation (Table 6) also demonstrate that the difference in pressures were 
smaller than the 50% level of detection for the flow at V
.
O2 between 0.5 and 1.0 L∙min-1.  
These results suggest that the increased pressures resulting from the addition of the SM at the 
lower levels of energy expenditure used in this investigation would not be detected in 
humans compared to using the same FFR without a SM.  These are the same levels of energy 
expenditure which occur with a significant portion of activities conducted by healthcare 
workers. 
 
5.4  Study Limitations 
 
While the ABMS is an accurate, reproducible, functional and useful tool to characterize the 
metabolic responses that can be produced by the use of respiratory protection, there are 
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limitations to its use.  For negative pressure respiratory protection, such as FFR, elastomeric 
air-purifying respirators, and gas masks, the ABMS measurements for the respirator’s dead 
space are affected primarily by the minute ventilation, more specifically, tidal volume.  As 
the normal user’s tidal volume decreases, the effect from respirator dead space becomes 
greater.  Conversely, the opposite occurs as tidal volume increases, such as that in normal 
larger persons and exercise. In a field study, smaller healthcare workers (e.g., women) were 
more likely to experience intolerance for wearing FFR before the end of the shift 
(Radonovich et al., 2009).  The limitation, therefore, is characterizing respiratory protection 
with a tidal volume specific to the human data used to program the metabolic parameters of 
the ABMS, or a subset of subjects with a body size of 85-92 kg.   
Another limitation for the ABMS is that it does not respond, that is, 
respiratory protection for the ABMS does not cause changes in breathing times, breathing 
volumes/depths, or breathing patterns.  Humans respond to the changes in the breathing zone 
from the use of respiratory protection.  However, those stimuli produced by the results of 
using respiratory protection are masked by the human response.  The human response was 
similar to the ABMS measurements in a previous investigation (Sinkule and Turner, 2004).  
The stimuli from using various forms of respiratory protection, or types of FFR and 
treatments affecting FFR (e.g., SM), will vary in magnitude.  These effects were 
characterized in this investigation.  Some human participants are hyposensitive to CO2 and 
metabolic acidosis, and do not respond normally to increased CO2 concentrations until 
hyperventilation occurs at exhaustive workloads (Whipp, Davis, and Wasserman, 1989). 
Subjective responses from the use of FFR with or without a SM cannot be 
reported from data using the ABMS.  For studies that examined FFR with and without SM, 
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and did not report inspired gases, the subjective responses included a gender-related 
reduction in tolerance time (Radonovich et al., 2009); greater comfort using FFR with 
exhalation valve +SM at 1.7 mile∙hour-1 treadmill speed compared to 2.5  mile∙hour-1 
(Roberge et al., 2010); and, reduced respiratory rate.  The subjective responses reported in 
FFR + SM studies using human subjects without measuring inhaled gases, however, was 
limited by a variety of research designs with their own limitations; e.g. subjective tolerance 
time of the FFR among subjects that included subjects that smoke (Radonovich et al., 2009), 
a research design that did not allow for stratification based on various physical activities 
throughout the experimental period (Radonovich et al., 2009), research test participants were 
not stratified based upon age (Roberge et al., 2010; Radonovich et al., 2009), and  reporting 
mixed (inhaled and exhaled) respiratory gases (Roberge et al., 2010).  
The relationship between physical activity and aging is important for the 
research design as well as its relevance for an aging workforce.  Between July, 2007, and 
March, 2009, the proportion of licensed registered nurses (RN) under the age of 30 in 
California decreased from 7.6% to 6.9%, and the age range of 50-59 years of age had the 
largest proportion of RNs for both 2007 (30.3%) and 2009 (29.6%) (Spetz, 2009).  The 
largest difference between 2007 and 2009 occurred in the 60-69 age range, which were 
12.7% and 16%, respectively.  The health care employee’s functional capacity to accomplish 
their occupational activities increases to approximately age 30, thereafter decreases with 
increasing age (McArdle et al., 2010).  Muscle mass reduction with aging, 40-50% between 
25 and 80 years, is the single largest factor that contributes to decreasing muscle strength 
even among physically active adults (McArdle et al., 2010).  Since the physical activities that 
are possible for health care workers can range from 1.8 METs (sitting and writing) to 7.5 
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METs (moving/pushing objects 75 pounds+), the effects of engaging with these activities 
will vary with worker’s age (Ainsworth et al., 2000).  For women 60-69 years old, 7.5 METs 
is above the 35th percentile for their predicted maximal aerobic power (American College of 
Sports Medicine, 2010).  When compared to women 20-29 years old, this same amount of 
work is above the 1 percentile (American College of Sports Medicine, 2010).  Physical 
activities, therefore, are not the same for all workers regardless of their age.  The same 
applies for gender differences as well (American College of Sports Medicine, 2010; McArdle 
et al., 2010). 
5.5  Conclusions 
 
Approximately 10% of commercially-available NIOSH-approved FFR models were 
examined with and without SM using the ABMS to characterize metabolic responses in an 
attempt to understand the implications of the recommendation to apply a SM over the FFR to 
extend the respirator’s useful life for healthcare workers.  Conclusions for this investigation 
include the following:   
1. generally, average inhaled CO2 concentration decreased and average inhaled 
O2 concentration increased with increasing oxygen consumption in FFR and 
FFR with SM;  
2. peak exhalation pressure and peak inhalation pressure increased with 
increasing oxygen consumption, but more so in FFR with SM;  
3. compared to FFR without SM, higher average inhaled CO2 concentrations 
were observed in 4 of 6 workloads among FFR with SM; 
4. the addition of the SM to horizontal flat-fold FFR at 2OV of 1.0 and 1.5 
L∙min-1 caused a reduction in average inhaled CO2 concentrations and an 
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increase in average inhaled O2 concentrations due to the effects of the 
(horizontal flat-fold) SM on the FFR dead space; and, 
5. the average inhaled CO2 concentrations were above the NIOSH STEL for all 
FFR, both without and with SM (Table 10), and the reciprocal changes 
adversely affected the average inhaled O2 concentrations for most FFR 
(<19.5%), also with and without SM (Table 11) . 
 
At the lower levels of energy expenditure, this investigation provided evidence to suggest 
that the IOM recommendation of adding a SM over FFRs in order to extend the daily 
duration of FFRs and reduce the consumption of FFRs during a pandemic would produce 
clinically small changes in inhaled breathing gases and breathing pressures resulting in a 
minimal effect on physical work performance, and the amount and direction of change is 
affected by the type of FFR and shape of the SM.  In addition, the evidence also indicates 
possible improvements in inhaled breathing gases caused by the effects in the dead space 
characteristics of the FFR by the shape of the SM. 
5.6  Recommendations for Future Research 
 
Future research may consider human subject testing of various FFR models, adjusted for age 
and gender, while measuring time-weighted mean inhaled CO2 and O2 gas concentrations 
and comparing the responses to average inhaled CO2 and O2 gas concentrations from the 
ABMS.  This proposed research may provide a connection of ABMS results with human 
subject responses for use in the development of an ABMS-based standard test procedure for 
evaluating negative-pressure air-purifying respiratory protective devices.  Certain special 
groups also may benefit from exploratory research using the ABMS to evaluate respiratory 
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protection, e.g. children that use respiratory protection while performing activities in the 
agricultural industry. 
 
Table 10:  Value Ranges for Average Inhaled Carbon Dioxide Concentrations  (%) Among 
FFR With and Without SM                                                            
Oxygen Consumption,                                                           Horizontal                  Other 
         L∙min-1                 Treatment           Cup (n = 18)     Flat-fold (n = 6)      Flat-fold (n = 6)   
 
           0.5                       N95 only             1.57 – 3.48           2.00 – 4.52             2.04 – 3.55 
                                       N95 + SM           2.26 – 3.60           2.30 – 4.00             2.38 – 3.51 
 
           1.0                       N95 only             1.08 – 3.07           1.29 – 4.47             1.27 – 3.08 
                                       N95 + SM           1.56 – 3.30           1.46 – 2.70             1.86 – 2.13 
 
           1.5                       N95 only             1.33 – 4.02           1.43 – 5.16             1.35 – 3.71 
                                       N95 + SM           1.90 – 3.52           1.78 – 2.92             2.10 – 2.32 
 
           2.0                       N95 only             0.81 – 2.69           0.87 – 3.04             0.92 – 2.57 
                                       N95 + SM           1.28 – 2.67           1.28 – 2.07             1.41 – 1.78 
 
           2.5                       N95 only             0.67 – 2.59           0.77 – 2.89             0.79 – 2.36 
                                       N95 + SM           1.06 – 2.57           1.12 – 1.84             1.33 – 1.67 
 
           3.0                       N95 only             0 76 – 2.68           0.98 – 3.10             0.89 – 2.97 
                                       N95 + SM           1.56 – 2.66           1.36 – 2.29             1.45 – 2.02 
                                                                                                                                                    _          
Values are minimum - maximum 
N95 only = FFR alone, N95 + SM = FFR with SM cover 
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Table 11:  Value Ranges for Average Inhaled Oxygen Concentrations  (%) Among FFR With 
and Without SM   
                                                                  
Oxygen Consumption,                                                           Horizontal                  Other 
         L∙min-1                 Treatment           Cup (n = 18)     Flat-fold (n = 6)      Flat-fold (n = 6)   
 
           0.5                       N95 only          15.79 – 18.77        14.82 – 17.96        16.09 – 18.27 
                                       N95 + SM        15.81 – 17.57        15.61 – 17.51        15.90 – 17.79 
 
           1.0                       N95 only          16.75 – 19.62        15.30 – 19.20        16.91 – 19.27 
                                       N95 + SM        16.91 – 18.97        17.61 – 19.01        18.08 – 18.49 
 
           1.5                       N95 only          16.00 – 19.43        14.80 – 19.12        16.47 – 19.33 
                                       N95 + SM        16.99 – 18.90        17.66 – 18.86        18.15 – 18.39 
 
           2.0                       N95 only           17.78 – 20.04       17.57 – 19.81        17.94 – 19.85 
                                       N95 + SM         18.11 – 19.43       18.65 – 19.47        18.79 – 19.22 
 
           2.5                       N95 only           18.10 – 20.20       17.80 – 19.93        18.26 – 20.04 
                                       N95 + SM         18.29 – 19.66       18.92 – 19.61        18.93 – 19.39 
 
           3.0                       N95 only           18.06 – 20.10       17.70 – 19.73        17.72 – 19.96 
                                       N95 + SM         18.04 – 19.41       18.52 – 19.42        18.59 – 19.29 
                                                                                                                                                    _          
Values are minimum - maximum 
N95 only = FFR alone, N95 + SM = FFR with SM cover 
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